Form 8-K CLEVELAND BIOLABS INC For: Aug 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Cleveland Biolabs (CBLI) Reports Q2 Loss of $1.12
August 12, 2015 7:32 AM EDTCleveland Biolabs (NASDAQ: CBLI) reported Q2 EPS of ($1.12), versus ($1.53) reported last year. Revenue for the quarter came in at $329.9 million, versus $562.1 million reported last year.
For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.
... More